Yes at the onset they were promised a quicker enrollment so interim 2nd quarter was not out of the question. Reality became apparent when they were not seeing the enrollment numbers as promised by CRO it's even possible other psoriasis trials are going on at the same time. Now that they have a better account of trial participants they can accurately target readout 3rd quarter. To me another 30-60 days is not a big deal but some want it to be.
News 
Market Data 
Discover 
